What should be the first-line treatment for unexplained infertility in women over 40 years of age - ovulation induction and IUI, or IVF?
- PMID: 20034413
What should be the first-line treatment for unexplained infertility in women over 40 years of age - ovulation induction and IUI, or IVF?
Abstract
The tendency to postpone childbearing in developed countries and the relatively high rate of infertility in older women contribute to an increase in the portion of women aged 40 years and older opting for infertility treatments. The main factor for infertility in this group is oocyte senescence, but since this process does not have a specific diagnosis many of those will be classified as having 'unexplained infertility'. The efficacy of the traditional clinical approach for 'unexplained infertility' in older women is questionable. Reviewing the current literature, clomiphene citrate seems to be inefficient in this group of patients, while delivery rates of gonadotrophins and intrauterine insemination cycles are less than 5%. Although low in absolute terms, IVF is more efficient. The chance for delivery, however, diminishes with each year of age above 40. Therefore, after a short trial of gonadotrophins and intrauterine insemination, women aged 40-41 years should be quickly referred to IVF. At an older age, IVF is the primary treatment option.
Similar articles
-
The role of intracytoplasmic sperm injection in non-male factor infertility in advanced maternal age.Hum Reprod. 2017 Jan;32(1):119-124. doi: 10.1093/humrep/dew298. Epub 2016 Nov 16. Hum Reprod. 2017. PMID: 27852688
-
Low-dose human menopausal gonadotrophin versus clomiphene citrate in subfertile couples treated with intrauterine insemination: a randomized controlled trial.Hum Reprod. 2015 May;30(5):1079-88. doi: 10.1093/humrep/dev062. Epub 2015 Mar 18. Hum Reprod. 2015. PMID: 25788569 Clinical Trial.
-
Intrauterine insemination with gonadotropin stimulation or in vitro fertilization for the treatment of unexplained subfertility: a randomized controlled trial.Fertil Steril. 2017 Jun;107(6):1329-1335.e2. doi: 10.1016/j.fertnstert.2017.03.028. Epub 2017 May 10. Fertil Steril. 2017. PMID: 28501361 Clinical Trial.
-
Unexplained infertility: an update and review of practice.Reprod Biomed Online. 2012 Jun;24(6):591-602. doi: 10.1016/j.rbmo.2012.02.021. Epub 2012 Mar 7. Reprod Biomed Online. 2012. PMID: 22503948 Review.
-
Diagnosis and management of unexplained infertility: an update.Arch Gynecol Obstet. 2003 Feb;267(4):177-88. doi: 10.1007/s00404-002-0300-0. Epub 2002 May 4. Arch Gynecol Obstet. 2003. PMID: 12592415 Review.
Cited by
-
Disrupting the biological clock: Fertility benefits, egg freezing and proactive fertility management.Reprod Biomed Soc Online. 2021 Dec 10;14:239-250. doi: 10.1016/j.rbms.2021.11.004. eCollection 2022 Mar. Reprod Biomed Soc Online. 2021. PMID: 35252599 Free PMC article.
-
The "graying" of infertility services: an impending revolution nobody is ready for.Reprod Biol Endocrinol. 2014 Jul 9;12:63. doi: 10.1186/1477-7827-12-63. Reprod Biol Endocrinol. 2014. PMID: 25012752 Free PMC article.
-
A comparison of oral versus injectable ovarian stimulation in IUI in women ≥38 years of age with decreased ovarian reserve.Arch Gynecol Obstet. 2021 Jun;303(6):1607-1616. doi: 10.1007/s00404-020-05897-5. Epub 2021 Jan 3. Arch Gynecol Obstet. 2021. PMID: 33389112
-
Ovulation induction and intrauterine insemination in women of advanced reproductive age: a systematic review of the literature.J Assist Reprod Genet. 2022 Jul;39(7):1445-1491. doi: 10.1007/s10815-022-02551-8. Epub 2022 Jun 22. J Assist Reprod Genet. 2022. PMID: 35731321 Free PMC article.
-
What is the best treatment option for infertile women aged 40 and over?J Assist Reprod Genet. 2013 Jun;30(5):667-71. doi: 10.1007/s10815-013-9980-6. Epub 2013 Mar 29. J Assist Reprod Genet. 2013. PMID: 23536151 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical